# Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study

> **NCT00185809** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 25 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00185809
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2010-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185809, "Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00185809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*